ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Vontobel Financial Products Gmbh

Vontobel Financial Products Gmbh (F06717)

0.00
0.00
(0.00%)
Closed July 29 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
0.00
Financial Volume
-
VWAP
-

F06717 Latest News

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107

Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 PR Newswire PLYMOUTH MEETING, Pa., July...

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024

INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa., July 25, 2024 PLYMOUTH MEETING, Pa., July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO...

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway

INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire PLYMOUTH MEETING, Pa., July 11, 2024 Award recognizes the...

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer

INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer PR Newswire PLYMOUTH MEETING, Pa., July 2, 2024 Mr. Egge brings over 25 years of biopharmaceutical experience building...

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., July 1, 2024 PLYMOUTH MEETING, Pa., July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology...

INOVIO Added to Russell 2000® Index Effective July 1, 2024

INOVIO Added to Russell 2000® Index Effective July 1, 2024 PR Newswire PLYMOUTH MEETING, Pa., July 1, 2024 PLYMOUTH MEETING, Pa., July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a...

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc. PR Newswire PLYMOUTH MEETING, Pa., June 4, 2024 PLYMOUTH MEETING, Pa., June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a...

INOVIO Reports Inducement Grants Under Inducement Plan

INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., May 31, 2024 PLYMOUTH MEETING, Pa., May 31, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560081104.971.6522188.57090346DE
26000100.6104.927.3354468.41225936DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
FDAFidia
0.38 €
(28.81%)
777.35k
WSOGESWarr Soges Group
0.10 €
(23.46%)
1,000
WFCH25Franchetti SPA
2.198 €
(18.17%)
3.99k
WTWL24TraWell Co SA
0.289 €
(15.65%)
4
1PHIAKoninklijke Philips NV
27.15 €
(14.27%)
7.08k
WTMP25TPM Group SpA
0.001 €
(-75.00%)
99.65k
WGSR24G Rent Spa
0.0025 €
(-68.75%)
3k
WAMB26Ambromobiliare SpA
0.026 €
(-67.50%)
12.5k
WTKF24Take Off SpA
0.0025 €
(-63.77%)
50k
WRFLTCRedfish Longterm Capital Spa
0.03 €
(-25.00%)
66.51k
TITTelecom Italia SpA
0.2292 €
(0.31%)
81.71M
ISPIntesa Sanpaolo Spa
3.677 €
(-0.74%)
58.46M
SPMSaipem Spa
2.207 €
(-0.94%)
23.42M
STLAMStellantis NV
15.626 €
(-3.34%)
20.26M
ENELEnel Spa
6.652 €
(-0.27%)
14.46M

Discussion

View Full Feed
INFINITI INFINITI 4 minutes ago
Looking good for a breakout tomorrow
TIVC
JRoon71 JRoon71 5 minutes ago
Aaron Berg's new employment agreement. Mostly the same as Holt's, but the option hurdles are lower.
AMRN
Steady_T Steady_T 5 minutes ago
The Nov PR was an acknowledgement of eligibility for the centralized process. It made no reference to LOI.

The LOI states a date that the company expects to submit its MAA. That date has to be a minimum of 7 months after the LOI date.
I have asked IR about the LOI and got an
AVXL
bull runs bull runs 5 minutes ago
Actually it doesn’t take getting those like you to respond to many posts, before you are running on EMPTY!😂🤣😂🤣
Foursticks Foursticks 5 minutes ago
Go put your head in the sand!
CEOS
waterchaser waterchaser 6 minutes ago
The only Miro translation I can identify is “bashers”.

Something he’s been screaming for at least 15 years.

I know… I was on the receiving end of many of those outbursts.
HIRU
kund kund 6 minutes ago
How about this: He is expecting EMA approval and preparing to launch the drug, which is why he needs the money.

Reality is he need money for another trial...he screwed up with his soon, very soon and "the new big is small" mindset.
AVXL
JACKPOT JACKPOT 7 minutes ago
In this penny environment, I doubt it BUT I wish it doe$ for everyone's sake.
GDVM
BBANBOB BBANBOB 7 minutes ago
Personally looking for the gap at 98? to close with this round!!!
They will NOT let this move forward with a GAP ifin it is gonna hit 100 plus

ALL imho
COOP
fink fink 7 minutes ago
And it would be sweet if ihub had a link to such info.
Funny how any topic goes some some dirt road for a few.

Argumentative to the point t of personal attacks is the sign of a pathetic ego stroking them selves.

Retail can't short unless they are over seas. Lik
PickStocks PickStocks 8 minutes ago
Did you hear XXXX is going to help with distribution real soon…..got to believe your own bs….
COOP
redspeed redspeed 8 minutes ago
B2B is even tougher than B2C and the graveyard of B2C search engines is littered with great ideas and good intentions. Look forward to hearing how many business you signed up and how much revenue you are generating, as expectations are sky high with the $8M market cap. Most companies will just use L
MONI
OMOLIVES OMOLIVES 8 minutes ago
I think what counters that easily is the no pain aspect and discreteness. Not to mention the length of time. If this works..as the FDA gig noted it does.....it's a big deal.
DROR
QuantumTravesty QuantumTravesty 9 minutes ago
Serb-a-lish to English translation? Anyone, Bueller? Anyone?
HIRU
kund kund 9 minutes ago
It's just the registration, but I wouldn't be surprised if they actually dilute this week. There will likely be one more pump before that happens; this pattern is common with many small biotech companies, and Anavex is no different.

Never trust management completely—they often say one
AVXL
al44 al44 9 minutes ago
Only fooled the wokeholes-

https://media.gettr.com/group4/getter/2024/07/29/22/bb9730a5-b1ae-5be8-850c-c0064eae53bc/b966bd690212a053e7d691c306a84e5f_768x0.png
jog49 jog49 9 minutes ago
"Name one person who has been right in the last 16 years. So it doesn't matter"

ME! I said it would NEVER end and I've been flawless for 16 years and the meter continues to run.
FNMA
AlwaysRed AlwaysRed 9 minutes ago
STOP listening to metal salesmen!

https://tradingeconomics.com/commodity/silver

"Still, a dismal industrial outlook and persistent demand concerns in top consumer China continued to weigh on market sentiment. Expectations that silver demand from the renewable energy sec
SLV
kspar1 kspar1 9 minutes ago
I'll be 100 in 2052.
2027 is just around the corner!
;)
AVXL
jimr1717 jimr1717 10 minutes ago
Great DD!
IFUS
JRoon71 JRoon71 10 minutes ago
Yes, I saw that. I can't quickly access Holt's Agreement to compare. But that is interesting wording.
AMRN
konshe konshe 10 minutes ago
If that is a case, CEO can sue FDA?
RDGL
ignatiusrielly35 ignatiusrielly35 10 minutes ago
Maybe Missling will give shares to the large shorts so they go away. Anybody’s guess. All speculation.
AVXL
hweb2 hweb2 10 minutes ago
Good luck on IART. With thousands of stocks to pick from, I still don't get the appeal. The management team seems totally incompetent. Just look at the stock price down nearly 70% over the past few years. It's disappointment after disappointment from them lately. Plus GAAP earnings are a tiny f
IART